Chapter 7. Antibody Contract Manufacturing Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. North America
7.3.1. U.S. Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Landscape
7.3.2.4. U.S. Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Landscape
7.3.3.4. Canada Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Landscape
7.3.4.4. Mexico Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. Europe Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Landscape
7.4.2.4. UK Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Landscape
7.4.3.4. Germany Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Landscape
7.4.4.4. France Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Landscape
7.4.5.4. Italy Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Landscape
7.4.6.4. Spain Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Landscape
7.4.7.4. Denmark Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Landscape
7.4.8.4. Sweden Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Landscape
7.4.9.4. Norway Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. China
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Landscape
7.5.2.4. China Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Japan
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Landscape
7.5.3.4. Japan Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Landscape
7.5.4.4. India Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Landscape
7.5.5.4. South Korea Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Australia
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Landscape
7.5.6.4. Australia Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Thailand
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Landscape
7.5.7.4. Thailand Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Latin America Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Landscape
7.6.2.4. Brazil Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Landscape
7.6.3.4. Argentina Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Middle East and Africa
7.7.1. Middle East and Africa Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Landscape
7.7.2.4. Saudi Arabia Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Landscape
7.7.3.4. UAE Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.4. South Africa
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Landscape
7.7.4.4. South Africa Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Landscape
7.7.5.4. Kuwait Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 4 Global Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 5 Global Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 6 Global Antibody Contract Manufacturing, by Region, 2018 - 2030 (USD Million)
Table 7 U.S. Antibody Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 8 U.S. Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 9 U.S. Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 10 U.S. Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 11 U.S. Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 12 U.S. Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 13 U.S. Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 14 U.S. Canada Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 15 Canada Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 16 Canada Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 17 Mexico Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 18 Mexico Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 19 Mexico Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 20 Europe Antibody Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 21 Europe Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 22 Europe Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 23 Europe Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 24 Germany Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 25 Germany Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 26 Germany Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 27 UK Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 28 UK Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 29 UK Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 30 France Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 31 France Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 32 France Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 33 Italy Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 34 Italy Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 35 Italy Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 36 Spain Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 37 Spain Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 38 Spain Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 39 Denmark Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 40 Denmark Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 41 Denmark Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 42 Sweden Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 43 Sweden Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 44 Sweden Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 45 Norway Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 46 Norway Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 47 Norway Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Antibody Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 52 China Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 53 China Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 54 China Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 55 Japan Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 56 Japan Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 57 Japan Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 58 India Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 59 India Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 60 India Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 61 South Korea Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 62 South Korea Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 63 South Korea Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 64 Australia Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 65 Australia Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 66 Australia Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 67 Thailand Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 68 Thailand Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 69 Thailand Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 70 Latin America Antibody Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 71 Latin America Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 72 Latin America Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 73 Latin America Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 74 Latin America Antibody Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 75 Brazil Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 76 Brazil Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 77 Brazil Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 78 Argentina Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 79 Argentina Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 80 Argentina Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Antibody Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 84 Middle East & Africa Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 85 South Africa Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 86 South Africa Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 87 South Africa Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 90 Saudi Arabia Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 91 UAE Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 92 UAE Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 93 UAE Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 94 UAE Antibody Contract Manufacturing, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 95 Kuwait Antibody Contract Manufacturing, by Source, 2018 - 2030 (USD Million)
Table 96 Kuwait Antibody Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
Table 97 Kuwait Antibody Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Antibody Contract Manufacturing, Market Segmentation
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Market Dynamics
Fig. 8 Market Driver Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 PESTEL Analysis, By SWOT Analysis
Fig. 12 Regional Marketplace: Key Takeaways
Fig. 13 Global Antibody Contract Manufacturing, for Monoclonal Antibodies, 2018 - 2030 (USD Million)
Fig. 14 Global Antibody Contract Manufacturing, for Polyclonal Antibodies, 2018 - 2030 (USD Million)
Fig. 15 Global Antibody Contract Manufacturing, for Others, 2018 - 2030 (USD Million)
Fig. 16 Global Antibody Contract Manufacturing, for Mammalian, 2018 - 2030 (USD Million)
Fig. 17 Global Antibody Contract Manufacturing, for Microbial, 2018 - 2030 (USD Million)
Fig. 18 Global Antibody Contract Manufacturing, for Biopharmaceutical Companies, 2018 - 2030 (USD Million)
Fig. 19 Global Antibody Contract Manufacturing, for Research Laboratories, 2018 - 2030 (USD Million)
Fig. 20 Global Antibody Contract Manufacturing, for others, 2018 - 2030 (USD Million)
Fig. 21 Regional Outlook, 2024 & 2030
Fig. 22 U.S. Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 23 U.S. Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 24 Canada Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 25 Mexico Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 26 Europe Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 27 UK Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 28 Germany Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 29 France Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 30 Italy Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 31 Spain Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 32 Denmark Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 33 Sweden Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 34 Norway Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 35 Asia Pacific Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 36 India Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 37 China Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 38 Japan Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 39 South Korea Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 40 Australia Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 41 Thailand Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 42 Latin America Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 43 Brazil Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 44 Argentina Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 45 Colombia Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 46 Middle East & Africa Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 47 South Africa Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 48 Saudi Arabia Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 49 UAE Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 50 Kuwait Antibody Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)